Related Experiment Video
Updated: Jun 4, 2026
Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Current status of pediatric/neonatal extracorporeal life support: clinical outcomes, circuit evolution, and
Rahul Vasavada1, Feng Qiu, Akif Undar
1Pediatric Cardiovascular Research Center, Department of Pediatrics, Milton S. Hershey Medical Center, Penn State Hershey College of Medicine, Hershey, PA 17033, USA.
Insights
Extracorporeal life support (ECLS) saves lives but has significant risks. Future translational research in ECLS technology can improve patient outcomes and reduce complications.
Area of Science:
- Cardiovascular Sciences
- Respiratory Medicine
- Biomedical Engineering
Background:
- Extracorporeal life support (ECLS) provides critical mechanical circulatory support for respiratory or cardiac failure.
- Survival rates vary, with neonates having better outcomes in respiratory failure and pediatric patients in cardiac failure.
- Despite technological advancements expanding ECLS indications, significant mortality and morbidity persist.
Purpose of the Study:
- To review the current status of ECLS, including survival rates and complications.
- To highlight the persistent challenges, particularly mechanical complications.
- To emphasize the role of translational research in advancing ECLS technology and patient care.
Main Methods:
- Review of existing literature on ECLS indications, outcomes, and complications.
- Analysis of survival data differentiating between neonatal and pediatric populations for respiratory and cardiac failure.
- Discussion of the impact of technological improvements on ECLS applications.
Main Results:
- ECLS demonstrates improved survival with expanded indications.
- Neonatal respiratory and pediatric cardiac ECLS cases show higher survival rates.
- Mechanical complications remain a significant issue, indicating a need for improved circuit technology.
Conclusions:
- ECLS is a vital technology for critical care but requires further refinement.
- Translational research is crucial for evaluating ECLS devices and driving technological innovation.
- Advancements in ECLS technology hold the potential to reduce complications and improve patient survival.
Abstract:
Extracorporeal life support (ECLS) offers lifesaving mechanical circulatory support for patients afflicted with respiratory and/or cardiac failure. Neonatal respiratory patients have higher survival rates compared to pediatric patients, while, for cardiac cases, pediatric patients are more likely to survive. The indications for ECLS have been expanded due to the improved technology and favorable outcomes. However, the rate of mortality and morbidity for ECLS patients remains significant. Mechanical complications still comprise a large percentage of ECLS complications, leaving definite room for improvement in ECLS circuit technology in the future. As a pre-clinical evaluating tool, translational research will provide more useful information for the selection of ECLS devices, encourage further development of ECLS technology, and, ultimately, benefit the patients.
